Understand genome combinations
to prevent diseases.
National genomic intelligence infrastructure. Optimizing biological compatibility to strengthen the health of future generations.
Operational Capabilities
Applied Biological Intelligence
Mate Choice Optimization
Scientifically optimizing compatibility for healthier generations.
Pharmacogenomics
Personalized medication strategies based on genetic profiles.
Global Compatibility
Ensuring genomic data interoperability across borders.
História
Timeline — The Evolution of Matching and Dating
Prehistoric times
Human pairing was driven by proximity, survival, and tribal belonging. Compatibility meant cooperation, safety, and shared resources rather than deliberate selection.
Historical societies → modern era
Families and communities shaped matchmaking through culture, religion and social trust — traditions still present today. Digital dating platforms later introduced algorithmic matching focused mainly on personality and appearance.
MHC-dependent mate preference evidence
Evidence that biological factors may influence attraction through immune-system genetic diversity: Wedekind C, Seebeck T, Bettens F and Paepke AJ, ‘MHC-dependent mate preferences in humans’, Proceedings of the Royal Society B Biological sciences (1995) 260, 245–249.
Excegen Genética molecular marker–assisted mating (Brazil)
Sergio Dani’s team at Excegen Genetica SA developed an award-winning STR molecular marker–assisted mating programme in animals, demonstrating improvements in fertility, health and genetic diversity management.
Pairomics seminal publication
Formal introduction of the Pairomics framework proposing genomic compatibility for reproductive counselling and medical matching: Dani SU, März W, Serrano-Neves PM and Walter GF, ‘Pairomics: the omics way to mate choice’, Journal of Human Genetics (2013) 58, 643–656.
Incorporation of Pairomics Inc.
Pairomics Inc. was established as a U.S. C-Corporation to translate the scientific concept into a scalable and ethical digital health platform.
Founder Institute, Swiss Cohort
Pairomics Inc. joined the Founder Institute Core Acceleration Programme (Swiss Cohort 2026), accelerating MVP validation, partnerships and investor readiness.
Ethics is not optional. It's our foundation.
We rigorously verify every data point and ensure military-grade encryption for all genomic assets.
- Military-grade Encryption
- Sovereign Data Residence
- Full User Control
- Transparent Audit Logs
AI Security Simulator
Simulate attack scenarios to verify our defenses.
Partnerships
For Investors
Pairomics is poised for rapid expansion, leveraging proprietary algorithms to capture the genomic intelligence market.
AI Generated Executive Summary
Pairomics is poised for rapid expansion, leveraging proprietary algorithms to capture the genomic in...
Access detailed financial reports and strategic roadmap.
View Investor Relations